| Primary |
| Lymphoma |
71.4% |
| Hodgkin's Disease |
14.3% |
| Pulmonary Fibrosis |
14.3% |
|
| Pneumonitis |
25.0% |
| Pyrexia |
25.0% |
| Refusal Of Treatment By Patient |
25.0% |
| White Blood Cell Count Decreased |
25.0% |
|
| Secondary |
| Hodgkin's Disease |
50.9% |
| Non-hodgkin's Lymphoma |
7.4% |
| Diffuse Large B-cell Lymphoma |
4.5% |
| Lymphoma |
4.3% |
| B-cell Lymphoma |
3.7% |
| Mantle Cell Lymphoma |
3.6% |
| Breast Cancer |
2.8% |
| Lung Neoplasm Malignant |
2.4% |
| Acute Lymphocytic Leukaemia |
2.2% |
| Acute Myeloid Leukaemia |
2.2% |
| B-cell Small Lymphocytic Lymphoma |
2.2% |
| Chronic Lymphocytic Leukaemia |
2.2% |
| Plasma Cell Myeloma |
2.2% |
| Hodgkin's Disease Recurrent |
2.1% |
| Haematological Malignancy |
1.6% |
| Malignant Lymphoid Neoplasm |
1.4% |
| Central Nervous System Lymphoma |
1.3% |
| Hodgkin's Lymphoma |
1.2% |
| Hodgkin's Disease Stage Iv |
1.0% |
| Product Used For Unknown Indication |
0.9% |
|
| Neutropenic Infection |
22.5% |
| Myelodysplastic Syndrome |
12.3% |
| Toxicity To Various Agents |
8.6% |
| Acute Myeloid Leukaemia |
8.2% |
| Osteonecrosis |
6.1% |
| Thrombocytopenia |
4.5% |
| Non-hodgkin's Lymphoma |
4.1% |
| Tuberculosis |
4.1% |
| Infection |
3.3% |
| Neurotoxicity |
3.3% |
| Neutropenic Sepsis |
2.9% |
| Traumatic Lung Injury |
2.9% |
| Vomiting |
2.9% |
| Acute Lymphocytic Leukaemia |
2.5% |
| Febrile Neutropenia |
2.5% |
| Pyrexia |
2.5% |
| Stem Cell Transplant |
2.0% |
| Bacterial Infection |
1.6% |
| Cardiac Failure |
1.6% |
| Hodgkin's Disease Recurrent |
1.6% |
|
| Concomitant |
| Hodgkin's Disease |
26.6% |
| Drug Use For Unknown Indication |
18.3% |
| Central Nervous System Lymphoma |
12.4% |
| Chemotherapy |
5.9% |
| Eczema |
4.1% |
| Angioimmunoblastic T-cell Lymphoma |
3.9% |
| Plasma Cell Myeloma |
3.6% |
| Partial Seizures |
3.1% |
| Lupus Nephritis |
2.8% |
| Glioblastoma Multiforme |
2.6% |
| Mental Disorder |
2.3% |
| Product Used For Unknown Indication |
2.3% |
| Acute Promyelocytic Leukaemia |
1.8% |
| Glioblastoma |
1.8% |
| Lymphoma |
1.8% |
| Breast Cancer Metastatic |
1.6% |
| Pain |
1.6% |
| Anaplastic Large Cell Lymphoma T- And Null-cell Types |
1.3% |
| Adult T-cell Lymphoma/leukaemia |
1.0% |
| Depression |
1.0% |
|
| White Blood Cell Count Increased |
12.3% |
| Respiratory Disorder |
8.8% |
| Syncope |
7.0% |
| Vomiting |
7.0% |
| Febrile Neutropenia |
5.3% |
| Hodgkin's Disease |
5.3% |
| Pulmonary Toxicity |
5.3% |
| Speech Disorder |
5.3% |
| Venoocclusive Disease |
5.3% |
| Gastrointestinal Perforation |
3.5% |
| Hepatic Cancer |
3.5% |
| Leukocytosis |
3.5% |
| Malignant Glioma |
3.5% |
| Malignant Neoplasm Progression |
3.5% |
| Mucosal Inflammation |
3.5% |
| Myelodysplastic Syndrome |
3.5% |
| Pancytopenia |
3.5% |
| Pulmonary Embolism |
3.5% |
| Sideroblastic Anaemia |
3.5% |
| Skin Discolouration |
3.5% |
|
